Answers are grounded in this paper and cite their sources.
AmpC β-lactamases are less commonly reported and are one of the major contributors to third-generation cephalosporin resistance within hospital settings. Emergence of new variants of this beta-lactamase complicates laboratory detection and treatment options. In the current investigation, we report the presence of bla CMY-225 , a new type of class C beta-lactamase from a teaching hospital in northeast India.
No takes yet. Share an insight, caveat, or question.
Wangkheimayum et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: